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Reactive oxygen species (ROS) production in
HepG2 cancer cell line through the application of
localized alternating magnetic field
Alberto Sola-Leyva,†a Ylenia Jabalera, †b Marı́a A. Chico-Lozano,b
Marı́a P. Carrasco-Jiménez,*a Guillermo R. Iglesias *c and
Concepción Jimenez-Lopezb
Recent studies have shown the potential of magnetic hyperthermia in cancer treatments. However, the
underlying mechanisms involved have not been yet fully described. In particular, the cell death related
to magnetic hyperthermia observed in cultures incubated with low concentration of magnetic
nanoparticles and under a low intensity alternating magnetic field, in which a macroscopic temperature
rise is not observed, is still not understood. In the present study, we investigate the production of
intracellular Reactive Oxygen Species (ROS) as a mechanism to induce cell death under these
conditions. In this study, the production and influence of ROS on the viability of HepG2 human
hepatoma cells (used as a model cell line) are analyzed under the application of variable magnetic
fields using hyperthermia agents, such as biomimetic magnetic nanoparticles (BMNPs) mediated by
magnetosome MamC protein from Magnetococcus marinus MC-1. The results show that intracellular
ROS production increases up to B90% following upon the exposure of AMF to HepG2 cells containing
BMNPs, which could determine the loss of cell viability (up to B40% reduction) without a significant rise
in temperature. Such ROS production is linked to mitochondrial dysfunction caused by the application
of AMF to cells containing BMNPs.
1. Introduction
Magnetic hyperthermia has gained interest as one of the most
promising alternatives for the local treatment of tumors. It is
based on the use of hyperthermia agents (like iron oxide
magnetic nanoparticles or other metallic nanoparticles) to
produce localized heat under the influence of alternating
magnetic field (AMF).1 The temperature increment of up to
42–46 1C at the tumor site results in the death of cancer cells by
apoptosis or necrosis.2–4 However, to induce such a tempera-
ture rise, high AMF needs to be applied and/or high concentra-
tions of magnetic nanoparticles (in the order of mg mL1)
are required. The required AMF and nanoparticle concentra-
tions are usually above the allowed limit for in vivo treatments
[Hf o 5  109],5 where nanoparticle concentrations are in the
order of mg mL1 to avoid potential cytotoxic effects.6 In fact,
there are few studies that have reported temperature incre-
ments up to cytotoxic levels in vitro, but in all these cases, either
the nanoparticle concentration used was too high and/or the
pairs (f, H) used were not within the biological range.7–9
However, surprisingly, some authors have observed a kind of
cytotoxic effect, in which even upon the application of AMF in
different cell lines incubated in vitro with magnetic nanoparticle
concentrations in the order of o 500 mg mL1, no detectable
macroscopic temperature rise was observed (or estimated).10–14
No explanation for such a phenomenon is plausible at the
moment. Our hypothesis and the focus of the present paper is
that the application of AMF to cell cultures incubated with
magnetic nanoparticles triggers some biological effects that are
responsible for cell death even if the concentration of these
nanoparticles is too low to induce a detectable temperature rise.
In this context, one of the biological effects, that may result
upon the application of AMF, is the generation of increased
levels of intracellular reactive oxygen species (ROS). In fact,
some studies have shown that magnetic nanoparticles produce
ROS by Fenton and Haber–Weiss iron-mediated reactions15 and
other authors have proposed cell damage by ROS increase upon
the application of AMF.16 ROS can damage DNA, proteins, and
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hence cellular function.17 This suggests that the generation of
ROS either by the magnetic nanoparticles that are in the cells
and/or by AMF could be one of the underlying mechanisms
causing cell death. However, it is not known whether intracel-
lular ROS production in this context can occur without detect-
able temperature rise or if such intracellular ROS production is
linked to the rise in temperature caused by hyperthermia.
Therefore, understanding whether or not ROS production
occurs upon the application of AMF and whether or not its
production requires a temperature rise, may provide new tools
to increase the efficiency of hyperthermia treatments against
cancer while keeping low the doses of magnetic nanoparticles
that need to be injected.
To address this study, biomimetic magnetic nanoparticles
(BMNPs) synthezized by the mediation of magnetosome MamC
protein from the magnetotactic bacterium Magnetococcus marinus
MC-1 were used as magnetic hyperthermia agents and HepG2
human hepatoma cell lines were used as a cell model. Then, the
ability of BMNPs as hyperthermia agents, their biocompatibility,
and internalization on cells as well as the in vitro temperature
increment and ROS production were evaluated.
2. Experimental
2.1. BMNPs synthesis
MamC was expressed and purified as recombinant protein
following the protocol described in the literature.18 Escherichia
coli TOP10 (Life Technologies: Invitrogen, Grand Island, NY,
USA) was transformed with the help of plasmid pTrcHis-TOPO
(Life Technologies: Invitrogen), which was used as a vector of
the MamC protein-coding gene (Mmc1_2265) coupled to a
hexahistidine tag coding sequence at its 50 terminus. The cells
were grown at 37 1C in Luria-Bertani (LB) broth supplemented
with 50 mg mL1 of ampicillin. After 5 hours of contact with
isopropyl-b-D-thiogalactopyranoside (IPTG, Fisher BioReagents,
Pittsburgh, PA, USA), the expression of recombinant MamC was
induced. Once expressed, the purification of the protein was
carried out under denaturing conditions by fast protein liquid
chromatography (FPLC, GE Healthcare) and immobilized-metal
affinity chromatography (IMAC, GE Healthcare, Chicago, IL,
USA). Finally, the fractions containing MamC were refolded at
4 1C through dialysis using 1 L of the buffers A (Tris 50 mM, NaCl
150 mM, urea 6 M, pH 8.5) and B (Tris 50 mM, NaCl 150 mM,
pH 8.5) as the starting and end points, respectively. The purity of
the protein was evaluated by SDS-PAGE electrophoresis.
The synthesis of BMNPs was carried out at 25 1C and 1 atm total
pressure obtained from oxygen-free solutions protocol described
in ref. 18 and 19 containing 3.5 mM Na2CO3, 3.5 mM NaHCO3,
2.78 mM Fe(ClO4)2, 5.56 mM FeCl3, and 10 mg mL
1 recombinant
MamC at a pH value of 9. All the experiments were performed
under anaerobic conditions inside an anaerobic Coy chamber
(96% N2/4% H2, Coy Laboratory Products, Grass Lake, MI, USA).
The samples were incubated for 30 days and then the solids
were magnetically concentrated, washed three times with
deoxygenated Milli-Q water, and stored in HEPES buffer (pH
7.4) inside the Coy Chamber at 25 1C.
2.2. BMNPs characterization
Transmission electron microscopy (TEM) analyses were per-
formed with a STEM Philips Model CM20 microscope on
ultrathin sections (50–70 nm) prepared by embedding the
nanoparticles in the Embed 812 resin and then cutting them
using a Reichert Ultracut S microtome (Leica Microsystems
GmbH, Wetzlar, Germany). The ImageJ 1.47 software was used
to measure particle sizes on multiple micrographs with over
1000 nanoparticles measured to ensure reproducibility. Hysteresis
cycles were carried out at 300 K and 5 K by using a super-
conducting quantum interference device (SQUID) 5 T magneto-
meter (Quantum Design MPMS XL, San Diego, CA, USA).
Electrophoretic mobility measurements were carried out in a
Zetameter Nano-ZS (Malvern Instruments, Malvern, UK) at
25 1C. The stock suspensions of BMNPs were prepared in
20 mL of oxygen-free NaClO4 (10 mM). The aliquots of 200 mL
from each stock were suspended in flasks containing oxygen-
free NaClO4, and the pH was adjusted from 2 to 9. The samples
were sonicated for 2 min, and the electrophoretic mobility was
immediately measured.
Basic mineral characterization [thermogravimetric analyses,
specific surface area by Brunauer–Emmett–Teller (BET), and
ZF–ZFC curves] can be found in the literature.18,20 The BMNPs
used in the present study are superparamagnetic, contain up to
5 wt% MamC, have the specific surface area of B90 m2 g1, and
the blocking temperature of B145 K.20
2.3. Calorimetric and specific absorption rate determination
The Specific Absorption Rate (SAR) is estimated from the measure-
ment of time-dependent calorimetric heating in a home AMF.
Briefly, it consists of a four-turn air-cored coil made of water-
cooled copper pipe as the part of a resonant circuit powered by an
AC generator having an inner diameter of 4 mm. Two experiments
were performed: (i) five frequencies were selected, namely 136 kHz,
160 kHz, 200 kHz, 245 kHz, and 380 kHz, with a fixed magnetic field
strength of 10 kA m1 (ii) five magnetic field strengths were analyzed,
namely 6 kA m1, 10 kA m1, 12.5 kA m1, 15 kA m1, and 20 kA
m1, with a fixed frequency of 136 kHz. Both the frequency and the
magnetic field strength were measured in the center of the coil using
a magnetic probe (NanoScience Laboratories Ltd, Staffordshire, UK)
with a resolution of 10 mT. The change in temperature dT vs. time dt
was measured with an optical fiber thermometer (Optocon AG,
Dresden, Germany) during the first 20 s after turning on the field.
The samples to be evaluated were placed in the Eppendorf plastic
tubes (1.5 mL sample volume), containing 0.5 mL of sample volume
at a concentration of 10 mg mL1 in HEPES buffer.
The SAR value and Intrinsic Loss Power (ILP), defined as SAR
(H2f)1 to compare the performance of measured NPs under
different field conditions, were calculated by the classical
definition and using eqn (1) and (2):21,22


























































Finally, to evaluate the possible interference of the cell growth
media with alternating magnetic field, these media were evaluated
and compared with those obtained when BMNPs were suspended
in the HEPES buffer. In this case, a fixed frequency of 136 kHz and
a fixed magnetic field strength of 20 kA m1 were used.
A thermal imaging camera FLIR 60, with 320  240 pixels IR
resolution and thermal sensitivity o 0.045 1C (FLIR Systems,
Inc. Wilsonville, Oregón, USA), was used to measure the max-
imum temperature reached by the different concentrations of
BMNPs (from 0.1 to 20 mg mL1). Although the AMF was
applied for 1.5 hours, the images were taken after 5 minutes
of the treatment (time after which differences in the samples
were not observed).
2.4. Cell culture
The human hepatoma HepG2 cell line used in this work
was obtained from the European Collection of Animal Cell
Cultures (Salisbury, UK). The cells were cultured in Minimum
Essential Medium (MEM) including 10% heat-inactivated fetal
bovine serum (FBS) (MEM/10% FBS) supplemented with 2 mM
L-glutamine, 1% non-essential amino acids, 100 U mL1
penicillin, and 100 mg mL1 streptomycin. The cell cultures
were maintained in a humid atmosphere with 5% CO2 at 37 1C
and subcultured at a ratio of 1 : 10 once a week or when an
experiment required it.
2.5. BMNPs internalization
For the quantitative analysis of nanoparticle uptake, HepG2
cells (300 000 cells per well) were seeded in 12-well plates.
Subsequently, 300 mg mL1 BMNPs were added. After 24 h,
cells were washed with PBS, trypsinized, transferred to 2 mL
tubes, and centrifuged at 1000 rpm for 5 min. Then, the cell
pellets formed were dissolved in 37% HCl, mixed with 10%
H2O2, and incubated for 20 min at room temperature. Subse-
quently, the samples were treated with 1 mL of 1% potassium
thiocyanate in Milli-Q water, and their absorbance was mea-
sured at 490 nm. The concentration of nanoparticles in the
samples was calculated referencing the absorbance obtained to
a standard curve and the endogenous iron of cells was
subtracted.
2.6. Cell proliferation assay
HepG2 cells were seeded onto 96-well plates (10 000 cells per well)
and grown in MEM/10% FBS for 24 h. After 24 h, the medium
was removed and 100 mL of fresh medium containing BMNPs
(300 mg mL1) or just medium as control were added. Cell viability
was assayed by the crystal violet staining assay using a cell-number-
based standard curve as previously reported23 in the presence or
absence of AMF for 2 h. The absorbance of crystal violet in each
well was measured at a wavelength of 590 nm directly in plates
using a microplate reader (HTX Microplate Reader BioTek Instru-
ments, Vermont, USA).
2.7. Intracellular ROS analysis
Intracellular ROS were studied by using the fluorometric intra-
cellular ROS kit (MAK143, Sigma-Aldrich, Madrid, Spain) fol-
lowing the manufacturer’s recommendations. This kit provides
a fluorogenic sensor which reacts with ROS, resulting in a
fluorometric product proportional to the amount of ROS pre-
sent in live cells. In order to carry out these experiments, cells
were seeded onto 96-well black plates with clear bottoms for
fluorometric assays (20 000 cells per well) in MEM/10% FBS for
24 h in the presence or absence of NMNPs. The plates were
previously cut into 4-well blocks to fit the requirements of the
instrument that generates AFM. Then a volume of 100 mL per
well of Master Reaction Mix containing the fluorogenic
sensor was added and incubated for 1 h. Then, the cells
were exposed to AMF for 2 h. 0.5 mM of H2O2 was used as a
positive control and the fluorescence intensity was measured at
lex = 490/lem = 525 nm.
2.8. Cell micrographs by transmission electron microscopy
HepG2 cells, suspended in 1–5 mL tubes, were exposed to AMF
under the condition described above. Then TEM analyses were
performed as previously described in ref. 24. Briefly, glutaral-
dehyde and paraformaldehyde in cacodylate buffer were
used to fix the cell pellets. As a postfixed solution, 1% OsO4
containing 1% potassium ferrocyanide was added and kept
standing for 1 h at 4 1C in darkness. A series of washes were
performed, first by using 0.15% tannic acid in cacodylate
buffer, then cacodylate buffer, H2O, and finally, the samples
were incubated in 2% uranyl acetate for 2 h and washed few
times with H2O. Then, 50% to 100% ethanol solutions were
used for dehydration, and as the last step, the samples were
embedded in resin. Ultrafine sections were prepared by using a
Leica Ultramicrotome R and contrasted by using 1% aqueous
uranyl acetate for 5 min and lead citrate in a CO2-depleted
atmosphere. To visualize the ultrafine sections, A Zeiss Libra
Plus 120 electron microscope was used.
3. Results and discussion
3.1. Nanoparticle characterization
The particle size and morphology of BMNPs were analyzed by
TEM images. Fig. 1A shows that biomimetic crystals BMNPs
exhibited well-defined faces. These BMNPs show sizes ranging
from 20 to 60 nm, with an average crystal size of 37  7 nm
(Fig. 2B). The hysteresis cycles of BMNPs showed a typical
ferromagnetic behavior at 5 K, while at 300 K, these nano-
particles showed zero coercivity, which indicates their super-
paramagnetic character (Fig. 1C). The isoelectric point of
BMNPs was 4.4 (Fig. 1D), indicating the negative charge of
these nanoparticles at physiological pH. The negative charge
and the superparamagnetic character of BMNPs prevent their
magnetic aggregation in the absence of an external magnetic
field, while when this field is applied, BMNPs respond effi-
ciently with a magnetic saturation of 54 emu g1 (Fig. 1C).
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3.2. Alternating magnetic field response
Alternating magnetic field responses as a function of time were
obtained at four different frequencies at a fixed magnetic field
strength of 10 kA m1. Fig. 2A shows the time evolution of the
temperature of BMNP suspensions under the presence of an
AMF. For all the frequencies tested, BMNPs are able to raise the
effective temperature to kill tumor cells (42–46 1C)2,3 in less
than 20 s. Fig. 2B shows the temperature as a function of time
for the same BMNP suspensions under the influence of differ-
ent magnetic field strengths at a fixed frequency of 136 kHz.
Again, a rapid increase in temperature for magnetic field
strengths above 10 kA m1 in a few seconds can be observed.
Overall, all the samples are dependent on frequency and
magnetic field strength within the evaluated range.
The SAR and ILP values are represented in Fig. 3 and
Tables 1 and 2. The SAR values increase with the increase
in field frequency and field strength, as mentioned. On the
contrary, the intrinsic loss power is independent of frequency
and field strength, displaying values within the range of
4–7 nH m2 kg1, which are in agreement with the results
obtained by Iglesias et al.25
Note that the SAR and ILP values yielded by BMNPs are in a
high range than those reported in the literature.26–29 This
is interesting because previous studies have demonstrated that
magnetosomes respond significantly more efficiently to AC
field than magnetite nanoparticles of similar size produced
chemically.30,31 The high SAR and ILP values yielded by BMNPs
(chemically synthesized but in the presence of the magneto-
some protein MamC) evidence that, while produced chemically
(in the absence of bacteria), MamC-mediated BMNPs are not
like any other chemically synthesized magnetic nanoparticle. In
fact, it has already been demonstrated32–34 that MamC controls
the nucleation of magnetite by template, such an effect deter-
mines the number of nuclei, and as the system is Fe limited,
the effect also determines the growth of those nuclei and their
final larger size. MamC also controls the kinetics of crystal
growth, yielding crystals with high crystallinity that display
faces which are not observed in the absence of MamC.
Fig. 1 Nanoparticles characterization. (A) TEM image and (B) nanoparticles size distribution. (C) Hysteresis cycle of BMNPs at 300 K and 5 K. Inset:
Detail of the hysteresis cycle in the absence of external magnetic field at 300 K and 5 K. (D) z-potential of BMNPs.
Fig. 2 Time evolution of the temperature of the BMNPs suspensions. (A) Varying frequency at a fixed magnetic field strength of H = 10 kA m1;
(B) varying magnetic field strengths at a fixed frequency of 136 kHz. Sample volume 0.5 mL; particle concentration: 10 mg mL1.
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All these characteristics, that are lacking in purely inorganically
synthesized magnetite crystals, confer different magnetic prop-
erties as our group demonstrated previously18,20 and could
account for the enhanced SAR and ILP values. The analysis of
these results confirms that BMNPs will be a useful tool to
generate enough heat to raise the temperature of the tumor
tissue locally for the effective treatment of hyperthermia as
demonstrated in previous studies.35,36
3.3. Culture media effect
In order to disregard the effect of culture media on magnetic
hyperthermia response, as suggested previously by other authors,37
BMNPs were resuspended in MEM culture media and magnetic
field experiments were again performed under identical conditions
as those detailed above, but with a magnetic field strength of
H = 20 kA m1 and a frequency of 136 kHz. As it is shown in
Fig. 4 and Table 3, the MEM cell culture medium does not
affect the BMNP response to the magnetic field, and both the
ILP and SAR values are similar to those obtained in the control
sample (BMNPs in HEPES buffer). Therefore, these results
further add that BMNPs are promising nano-heater agents,
independent of the culture media used.
3.4. Temperature reduction by concentration or macroscopic
versus microscopic temperature
As shown before, detecting temperature rises at high concen-
tration (10 mg mL1) of BMNPs is not difficult. However, when
the concentration of BMNPs is reduced to a point that is not
cytotoxic [300 mg mL1 for our BMNPs6 or 100 mg mL1 for
many publications38,39], problems arise because at such low
concentrations, temperature increases can be negligible and in
some cases, extremely difficult to measure. At higher magnetic
nanoparticle concentrations, SAR values can be measured as
shown before, and a correlation between SAR, nanoparticle
concentration, magnetic field strength, and frequency can
be determined (Fig. 3). At a given frequency, magnetic field
strength, and particle concentration, SAR value can be calcu-
lated from the initial slope of the Temperature versus time
(dT/dt, Fig. 4) curve by using eqn (1). As an example, considering
a field of 20 kA m1, a frequency of 136 kHz, and a concentration
of 10 mg mL1, the SAR value for our BMNPs is 380 W g1 with
Table 1 Summary of SAR and ILP calculations at different frequencies and
at a fixed magnetic field intensity of 10 kA m1, after 20 s exposition time.










BMNPs 136  5 65  8 0.16 4.8  0.6
160  5 91  8 0.22 5.7  0.5
200  5 120  10 0.30 4.7  0.6
245  5 160  10 0.39 6.5  0.5
308  5 210  30 0.51 7.0  0.8
Table 2 Summary of SAR and ILP calculations at different magnetic field
strengths and at a fixed frequency of 136 kHz, after 20 s exposition time.










BMNPs 6.5  0.2 21  3 0.05 3.6  0.5
10  0.2 60  5 0.14 4.4  0.4
12.5  0.2 130  20 0.32 6.1  0.8
15  0.2 190  20 0.45 6.1  0.6
20  0.2 380  25 0.92 7.0  0.7
Fig. 4 Time evolution of the temperature of the BMNPs suspended in
HEPES and MEM. Dash lines represent the slope of each sample curve.
Magnetic field strength: H = 20 kA m1. Frequency: 136 kHz. Sample
volume 0.5 mL; particle concentration: 10 mg mL1.
Fig. 3 SAR and ILP of the BMNPs tested. (A) Variable frequencies and fixed magnetic field strength; (B) variable magnetic field strength and fixed
frequency. Sample volume 0.5 mL; particle concentration: 10 mg mL1.
Table 3 Summary of SAR and ILP calculations of BMNPs suspended both
in HEPES buffer and MEM culture media, H = 20 kA m1, Frequency
136 kHz
System SAR [W g1] Slope dT/dt [1C s1] ILP [nH m2 kg1]
BMNPs 380  25 0.92 7.0  0.3
BMNPs (MEM) 390  25 0.93 7.1  0.7
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a slope of 0.92 1C s1 for the first 30 s (Tables 2 and 3). Using
this value as a reference, under identical conditions, for the
concentration of BMNPs equal to 300 mg mL1 (nearly thirty-times
lower than 10 mg mL1, which is the concentration used in the
in vitro cytotoxicity test), it can be predicted that the temperature
increase will be lower than 0.03 1C s1, which is certainly very
difficult to measure. Even more, if we consider that the sample,
the coil, and the environment have to be heat-controlled and kept
at 37 1C operating under adiabatic conditions and that any
disturbance around could affect the measurement.
Given such a difficulty, and considering that the concen-
tration of magnetic nanoparticles is limited by the dose at
which they become cytotoxic, the only possibility to obtain
measurable temperature increases (as published by many
authors) is to raise both the frequency and intensity of the
magnetic field applied. However, there is also a tolerable
clinical limit for these magnitudes, which cannot be exceeded.
This is based on the product of field strength and frequency,
and it should not exceed 4.85  108 A m1 s1,40 or H–f r 5 
109 A m1 s1 as proposed by Dutz and Hergt,5 a limit overcome
in many in vitro tests published. The frequency and magnetic
field strength used in this study (H = 20 kA m1, frequency:
136 kHz, H–f B 2.7  109 A m1 s1) were chosen by taking
into account this H–f limitation and so was the BMNP
concentration range.
Under these conditions, the temperature increase as a func-
tion of BMNP concentration (from 100 mg mL1 to 20 mg mL1)
was tried to be measured by using a thermographic camera. As
can be seen in the thermal photograph in Fig. 5A, only high
concentrations of BMNPs (45 mg mL1) show a significant
increase in temperature. Conversely, when BMNP concentrations
are lower than 1 mg mL1, as in our in vitro experiment, the
temperature increase was not significant, and thus it was not
expected to be high enough to cause cell death. However,
interestingly, cell death did occur as shown below.
3.5. BMNP cell internalization
When incubated with 300 mg mL1 BMNPs, these BMNPs are
internalized via endocytosis as demonstrated by Jabalera et al.24
Cell internalization in present experiments was indirectly
determined by measuring the intracellular iron and also, by
observing this internalization by TEM. As can be seen in
Fig. 6A, the TEM micrographs show that there is BMNP inter-
nalization in HepG2 cells, and B108 mg mL1 of BMNPs (36%)
are internalized as shown in Fig. 6B.
3.6. Cytotoxicity and ROS evaluation
Cytotoxicity tests run by adding 300 mg mL1 of BMNPs to
HepG2 cells in the presence or absence of an alternating
magnetic field show that, at this concentration, BMNPs were
cytocompatible in the absence of AFM, but they become signifi-
cantly cytotoxic in the presence of AFM (Fig. 7A). In fact, under
the influence of AMF, BMNPs reduced HepG2 cell viability by
30% after 2 h. These results are in agreement with those
obtained in the literature;24 although, the reason for cytotoxi-
city could not be elucidated by these authors at that moment.
The fact that BMNPs become cytotoxic in the presence of AMF
was very interesting, especially because as stated above, the
temperature would rise enough to reach the 42 1C threshold
(Fig. 5). Therefore, temperature rise could not be claimed to
explain the cytotoxicity of BMNPs in the presence of AMF.
Interestingly, Fig. 7B shows that only in cells incubated with
BMNPs under AMF conditions, there was a significant intracel-
lular ROS production (100). This is relevant because ROS is a
well-known factor to cause cellular damage and it is precise
when cell viability was reduced and ROS production was
detected. Therefore, since temperature rise cannot be claimed
for this kind of cytotoxicity, we hypothesize that the increase of
intracellular ROS levels caused by the AMF applied to cells
containing BMNPs is responsible for cell death. It has been
widely described that the main sources of cellular ROS are
Fig. 5 Thermographic photographs of different particle concentrations.
(A) High concentration of BMNPs and (B) low concentration of BMNPs.
Magnetic field strength of 20 kA m1 and frequency of 136 kHz, for
5 minutes test.
Fig. 6 (A) TEM image of BMNPs compartmentalized in endosomes (Ed). (B) Quantitative analyses of BMNPs cellular uptake in HepG2. These experiments
were conducted twice in triplicates. ***p o 0.001.
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mitochondria and endoplasmic reticulum (ER). Our results
obtained from cells incubated with BMNPs having concen-
tration 300 mg mL1 under AMF show mitochondrial swelling
with disorganized cristae and vacuolization in ER cisternae
(Fig. 7E). Several authors reported that mitochondrial dysfunc-
tion generates ROS, which profoundly alters cellular physiology,
and as a consequence, ROS production by ER is activated.41,42 In
this context, a rise in cytosolic ROS production can be observed
indirectly from mitochondrial dysfunction as described by
Leadsham et al.43 Our results are in agreement with those
obtained by these authors and confirm that the aberrant
mitochondrial morphology could be responsible for the rise in
ROS production observed in these cells. None of these ultra-
structural aberrations were observed in cells in the absence of
AMF (Fig. 7C and D).
AMF has been previously observed to cause cell death in
cells incubated with magnetic nanoparticles as stated above,
and temperature rises were claimed to be responsible for such
death.7–9 However, either an over-recommended pair (f, H) was
applied44 or too large concentrations of magnetic nanoparticles
were used6 in many studies published so far. Other studies have
described non-temperature mediated processes to explain the
cell death of cells incubated with magnetic nanoparticles upon
exposure to AMF. In particular, Kozissnik et al.45 proposed a
magnetically mediated energy delivery causing selective cell
death or damage to intracellular structures due to the rota-
tion/translation of magnetic nanoparticles upon the applica-
tion of AMF.
Here we propose another alternative mechanism to explain
non-temperature mediated cell death following upon exposure
of cells containing BMNPs to AMF: intracellular ROS produc-
tion. It is worth noting that, under our experimental condi-
tions, such an intracellular ROS increase is not linked to a
significant temperature rise caused by AMF. Our results
demonstrate that the observed increase in intracellular ROS
caused by AMF is related to mitochondrial dysfunction. Never-
theless, other parameters may also account for that, such as the
movement/rotation of BMNPs upon AMF application, which
may cause the cell damage in intracellular structures. In fact,
the rotation of BMNPs after AMF application has previously
been shown to break liposomes containing BMNPs.35 This
hypothesis is in line with the findings of Kozissnik et al.45
Another parameter that may also account for intracellular ROS
production is the release of Fe from endocitic nanoparticles. If
BMNPs enters the cell through endocytosis, as proposed in the
literature,46 the acidic medium of lysosomes would partially
dissolve BMNPs and increase the bioavailability of intracellular
Fe, which, in turn, by means of the Fenton reaction, would also
result in ROS increase.47–49 Finally, the induction of heat
localized at nanoscale around magnetic nanoparticles without
detectable macroscopic temperature rise should also be con-
sidered as a potential cause of intracellular ROS production.
Such a nanoscale localized temperature rise could contribute to
alterations in cell physiology, resulting in ROS production and/
or cell death.1,50
4. Conclusions
The limitations conditioned by the (f, H) pair added to the low
doses of magnetite nanoparticles required to prevent in vitro
and in vivo temperature rises to reach the minimum threshold
necessary for causing cell death (temperature mediated) after
the application of AMF on cells incubated with magnetic
nanoparticles. However, cell death occurs even if this threshold
is not reached, and the mechanisms underlying this kind of cell
death are still unknown. The results from the present study
show that intracellular ROS production following upon AMF
Fig. 7 Effect of exposure of alternating magnetic field (AMF) on (A) cell viability and (B) intracellular ROS levels in HepG2. These experiments were
conducted twice in triplicates. *p o 0.05, ***p o 0.001. Ultrastructural alteration produced by AMF: (C) control HepG2 cells, (D) cells incubated with
BMNPs showed normal mitochondria (M) morphology. (E) Abnormally shaped and swollen mitochondria with disorganised cristae (M) and endoplasmic
reticulum (ER) such dilatation occurring in cells incubated with BMNPs under AMF condition.
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exposure of HepG2 cells containing BMNPs could be claimed to
explain the loss of cell viability without significant temperature
rises. This type of ROS production is linked to mitochondrial
dysfunction caused by the application of AMF to cells
containing BMNPs, and is not observed under these conditions
in the absence of AMF. This study attempts to identify and
understand the molecular mechanisms by which AMF causes
cell death, without mediating temperature, in cells containing
magnetic nanoparticles. These results could be exploited to
increase the efficiency of cancer treatments mediated by the
application of AMF to cells containing BMNPs, since cell death
could be potentiated by promoting the production of intracel-
lular ROS. Further research needs to be done in order to define
and control the mechanisms that contribute to ROS production
under these conditions with a goal of continuously developing
new ways to increase the efficiency of magnetic hyperthermia as
an alternative cancer treatment.
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